Skip to main content
. Author manuscript; available in PMC: 2008 Feb 1.
Published in final edited form as: Am J Cardiol. 2008 Jan 1;101(1):98–101. doi: 10.1016/j.amjcard.2007.07.055

Table 1.

Subjects characteristics by weight tertile

Variable <113 kg (n = 67) 113–137 kg (n = 67) >137 kg (n = 69) P
Age (years) 46 ± 12 45 ± 11 41 ± 11 0.055
Weight (kg) 98 ± 11 124 ± 7 161 ± 17 <0.001
Body Mass Index (kg/m2) 38 ± 4 45 ± 5 55 ± 7 <0.001
Waist circumference (cm) 114 ± 10 129 ± 9 150 ± 15 <0.001
Systolic blood pressure (mm Hg) 127 ± 14 135 ± 14 127 ± 15 0.002
Diastolic blood pressure (mm Hg) 71 ± 9 75 ± 11 72 ± 12 0.103
Total cholesterol (mg/dl) 193 ± 38 194 ± 37 188 ± 41 0.636
Low density lipoprotein cholesterol (mg/dl) 115 ± 32 112 ± 31 112 ± 37 0.883
High density lipoprotein cholesterol (mg/dl) 51 ± 12 50 ± 16 46 ± 11 0.058
Triglycerides (mg/dl) 134 ± 61 163 ± 103 152 ± 104 0.197
Glucose (mg/dl) 109 ± 37 113 ± 47 104 ± 21 0.428
Insulin (μU/mL) 16 ± 14 15 ± 12 21 ± 11 0.030
HOMA-IR 3.5 ± 3.3 3.9 ± 6.6 4.3 ± 3.0 0.725
Heart rate (beats per minute) 71 ± 10 73 ± 11 73 ± 13 0.351
Creatinine (mg/dl) 0.7 ± 0.1 0.7 ± 0.2 0.8 ± 0.2 0.134
Hemoglobin A1c (%) 6.2 ± 1.1 6.5 ± 1.6 6.1 ± 1.0 0.283
Men 8% 15% 38% <0.001
Smoker 48% 24% 48% 0.011
Hypertension 36% 48% 48% 0.469
Diabetes mellitus 30% 30% 29% 0.993
Angiotensin converting enzyme inhibitor use 13% 19% 17% 0.642
HMGCo-A reductase inhibitor use 27% 21% 17% 0.400